Newsroom

Theramex select CARA Life Sciences Platform to consolidate and digitise regulatory processes

February 1, 2023

Categories: Biotechnology, Pharma, Corporate, Finance & Investor

Exothera announces the appointment of Darren Leva as Chief Business Officer

February 1, 2023

Categories: Computing & Technology, Pharma, Corporate, Finance & Investor

German pharma company selects Generis’ CARA Life Sciences Platform to unify their clinical processes

January 18, 2023

Categories: Omics & Genetics, Corporate, Finance & Investor

GenNext Technologies appoints Dr. Lisa Jones of UCSD to the role of Chief Science Officer (CSO)

January 11, 2023

Categories: Omics & Genetics, Corporate, Finance & Investor, Clinical Diagnostics

Isohelix files US FDA 510k pre-submission for GeneFix Saliva DNA Collectors

January 11, 2023

Categories: General Laboratory, Corporate, Finance & Investor

GenNext Technologies announces the appointment of Dr. John Grant from Lemnos Advisory to its Board of Directors

January 10, 2023

Categories: Computing & Technology, Pharma, Corporate, Finance & Investor

Global pharmaceutical company Merz choose Generis’ CARA Life Sciences Platform to consolidate their R&D content

December 19, 2022

Categories: Biotechnology, Corporate, Finance & Investor

Thermo Fisher Scientific’s advanced analytical instruments receive R&D 100 Awards

December 15, 2022

Categories: Biotechnology, Healthcare, Corporate, Finance & Investor

Over £175 million for cutting-edge genomics research to help boost diagnosis and treatment for patients

December 13, 2022